Pharmaceutical Isolator Market is Expected to Grow at a CAGR over 9.57% from 2023 to 2032

Pune, India, March, 2023 /press release/- Market Research Future Published a Cooked Research Report on Pharmaceutical Isolator Market Research Report.

Market Research Future (MRFR) has published a cooked research report on the “Global Pharmaceutical Isolator Market” that contains information from 2018 to 2032. The pharmaceutical isolator market is expected to register a CAGR of 9.57% during the forecast period 2023-2032, to reach USD 16.29 Billion by 2032.

Pharmaceutical Isolator Market Highlights

The rising demand for pharmaceutical isolators across booming pharmaceutical & biotechnological sectors and growing R&D initiatives in the pharmaceutical industry are anticipated to fuel the growth of the global Pharmaceutical Isolator Market at a CAGR of 9.57% during the forecast period of 2023 to 2032 and is expected to have a market value of USD 16.29 Billion by 2032.

The global pharmaceutical isolator market is driven by several factors, increasing spending on R&D by the pharmaceutical & biotech companies and the initiatives undertaken by the government to supplement the growth of the pharmaceutical industry. For instance, as per the European Federation of Pharmaceutical Industries and Associations, in 2020, the pharmaceutical industry in Europe spent more than USD 44.55 billion on R&D. In addition, increasing the adoption of pharmaceutical isolators in emerging economies. However, complex and varied pharmaceutical isolator regulations across countries and a shortage of trained and experienced medical specialists are anticipated to hamper the market growth.

Segment Analysis

The global pharmaceutical isolator market is segmented into type, product type, product class, application, end user, and region. The type of segment is further segmented into open isolator and closed isolator. The product type is segmented into sterility test isolator, process isolator, and decontamination pass box. The product class segment is further segmented into ISO Class 3 and  ISO Class 5. The application segment is further segmented into sterility testing, sampling/ weighing/ distribution, animal laboratories, aseptic tissue handling/microbiology testing/pathogenic sampling, defiltration and drying, and others. The end user segment is further segmented into biopharma/cell & gene therapy companies, academic & research institutes, hospitals, and contract research organizations & contract manufacturing organizations.

Regional Analysis

The global pharmaceutical isolator market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World.

The North American region held the largest market share of 37.53% in 2021. This is due to the developed healthcare infrastructure, growing demand for pharmaceutical isolators, low operational costs, and the presence of many market players in the region. Additionally, the growth of the pharmaceutical industry in the US, coupled with rapid technological advancements in the pharmaceutical industry, provides continuous progress in medicines and bioscience. Furthermore, continuous progress in gene therapies has improved the demand for batch development of treatment methods for a small and specific population, thereby boosting the demand for pharmaceutical isolators in North America.

Europe is anticipated to witness significant growth over the forecast period owing to a rise in the demand for pharmaceutical isolators from pharmaceutical and biotechnological industries, high sterility assurance, and low operational costs. In addition, the surge in the use of toxic and hazardous materials, and technological advancements to an upsurge in the usage of aseptic methods are also key factors propelling the market's growth. Moreover, the strict regulations and policies of the government for the maintenance of drug safety will fuel the growth rate of the pharmaceutical isolator market in Europe.

The pharmaceutical isolator market in Asia-Pacific is being driven by growing healthcare expenditures and the growing usage of sterilized methods in the region. For instance, the Coronavirus outbreak in China led to the launch of several drugs to counter the coronavirus (COVID-19). It has also increased contract manufacturing in the country, leading to the growth of the pharmaceutical isolators market. Similarly, in Japan, Gilead's Remdesivir and Fujifilm's antiviral Avigan are in Phase III clinical trials. Thus, with the growing production by the biopharmaceutical industry, the pharmaceutical isolators market is likely to have vital growth opportunities in the forthcoming years.

The rest of the world is comprised of the Middle East, Africa, and Latin America. The adoption of advanced healthcare technologies and the growing demand for pharmaceutical isolators from small and midscale pharmaceutical industries have offered stable growth in the market. Furthermore, rising advancements such as portability, connectivity, grabbing the stationary position, growing focus on medical devices sterilization technology, and rising medical tourism are other important factors that will further increase lucrative market growth opportunities in the Middle East, Africa, and Latin America.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Pharmaceutical Isolator Market Research Report

MRFR recognizes the following companies as the key players in the global Pharmaceutical Isolator Market — Skan AG (Switzerland), Azbil Telstar s.l.u (Spain), Cytiva (US), NuAire Inc (US), Schematic Engineering Industries (India), MBraun GMBH (Germany), Fedegari Autoclavi S.p.A(Italy), Hosokawa Micron B.V (Netherlands), Syntegon Technology (Germany), Isotech design (Canada), and Getinge AB (Sweden).

Key Findings of the Study

• The global pharmaceutical isolator market is estimated to reach USD 16.29 Billion by 2032 at a CAGR of 9.57% during the assessment period.


• North America accounted for the largest share of 37.53% in 2021. This is due to the developed healthcare infrastructure, growing demand for pharmaceutical isolators, low operational costs, and the presence of a large number of market players in the region.


• Based on type, the open isolator segment accounted for the largest share in 2021 and is anticipated to be the fastest growing for the forecast period 2023-2032.


• Based on product type, the sterility test isolator segment accounted for the largest share in 2021 and is anticipated to be the fastest growing for the forecast period 2023-2032. 


• Based on product class, the ISO Class 5 segment accounted for the largest share in 2021 and is anticipated to be the fastest growing for the forecast period 2023-2032


• Based on application, the aseptic filling segment accounted for the largest share in 2021 and is anticipated to be the fastest growing for the forecast period 2023-2032.


• Based on end user, the biopharma/cell & gene therapy companies segment accounted for the largest share in 2021 and is anticipated to be the fastest growing for the forecast period 2023-2032.


• Some of the key players operating in the Pharmaceutical Isolator Market are — Skan AG (Switzerland), Azbil Telstar s.l.u (Spain), Cytiva (US), NuAire Inc (US), Schematic Engineering Industries (India), MBraun GMBH (Germany), Fedegari Autoclavi S.p.A (Italy), Hosokawa Micron B.V (Netherlands), Syntegon Technology (Germany), Isotech Design (Canada), and Getinge AB (Sweden).